The company gave me confidence that they have next-generation products for markets that they currently participate in. Additionally, for the large markets where they are not players, the company is developing compounds.

We think this is a good move for Johnson and Johnson. It boosts their pharmaceutical (sales) growth also brings them expertise in research and development of drug delivery.

These are dedicated doctors, who take care of very sick patients. It's a doctor's duty to care. Care in the field doesn't change.

Physicians themselves haven't lost anything. As long as revenue is there, they're getting paid.

We are a company where confidence and trust is held high. A company like ours is always going to choose the untainted opportunity. There is no reason to stand up for controversy.

Our ongoing stock repurchase program demonstrates the confidence we have in our company and shows our commitment to deliver long-term stockholder value. Our strong balance sheet and cash generation capability allow us to simultaneously invest in our current business and repurchase stock.